IBB
ETF
Biotechnology
NASDAQ
iShares Biotechnology ETF
$211.54
-1.89 (-0.89%)
Fund Overview
by iShares (BlackRock)
Tracks the Nasdaq Biotechnology Index with market-cap weighting. Large-cap biotech dominance from Amgen, Gilead, Regeneron, and Vertex, with a long tail of smaller clinical-stage companies.
AUM$7.8B
Expense Ratio0.44%
Holdings224
Dividend Yield0.2%
DistributionQuarterly
BenchmarkNasdaq Biotechnology Index
InceptionFeb 2001
ExchangeNASDAQ
Price Data
Open$213.62
Prev Close$213.43
Day Range$210.48 — $213.62
52W Range$107.43 — $179.64
52-Week Range
$107.43
$179.64
From 52W High
17.8%
From 52W Low
+96.9%
Investment Calculator
See how much dividend income IBB could generate based on its current price of $211.54 and 0.2% yield. Adjust the amount to estimate your quarterly distributions.
$
Shares Purchased
Amount Invested$9,942.38
Annual Income$19.88
Monthly Income$1.66
Based on current dividend yield of 0.2%. Actual distributions may vary. Past dividends do not guarantee future payments.
Biotechnology ETF Comparison
Top Biotechnology Stocks
View all →
| Stock | Price | Change | Market Cap |
|---|---|---|---|
| ABBV | $292.82 | -0.59% | 520.47B |
| AMGN | $457.93 | -0.95% | 252.64B |
| GILD | $170.26 | +1.60% | 208.95B |
| VRTX | $534.20 | -0.67% | 134.82B |
| REGN | $957.76 | +0.56% | 98.38B |
| MRNA | $206.80 | -3.93% | 90.54B |
| NTRA | $287.47 | -0.35% | 45.90B |
| RVMD | $162.69 | -2.50% | 37.37B |
| BIIB | $250.79 | -0.34% | 37.21B |
| ROIV | $38.71 | +0.26% | 28.64B |
IBB FAQ
What is IBB?
IBB is the iShares Biotechnology ETF, an exchange-traded fund managed by iShares (BlackRock). It tracks the Nasdaq Biotechnology Index and holds 224 Biotechnology securities with an expense ratio of 0.44%.
What is the expense ratio of IBB?
IBB charges an annual expense ratio of 0.44%, which means you pay $44.00 per year for every $10,000 invested. This fee is deducted automatically from the fund's returns.
Does IBB pay dividends?
Yes, IBB pays a 0.2% dividend yield, distributed quarterly. On a $10,000 investment, that works out to approximately $20.00 per year in dividend income.
Explore Biotechnology Stocks
View our full list of individual biotechnology stocks with prices, fundamentals, and analyst ratings.
Last updated: Nov 13, 2026 at 4:46 PM ET